Omega Funds
-
Type of investor
VC -
Based in
Boston -
Number of investments
6-10 -
Industry
biotech, medtechVisit website of
Omega Funds
Related News
13.01.2025 12:00
Windward Bio launches with $200 million Series A financing round
13.04.2022 15:00
CDR-Life Closes $76 million Series A Funding
16.09.2021 09:00
Anjarium Biosciences Raises CHF 55.5 Million Series A Financing
22.04.2020 15:21
Basel-based FoRx Therapeutics secures EUR 10 million seed round
14.06.2018 11:55
Andrew Alliance raises $14 million in series C round
17.12.2015 09:30
Xeltis acquires additional €3M in series B financing
16.11.2015 09:15
KUROS announces second closing of a CHF 20 million financing round
The new Swiss Venture Capital Report was published on 26 January. It analyses 304 financing rounds closed in 2020 and includes further article such as an interview with Michael Hengartner, President of the ETH Board, and a list of Swiss "soonicorns". 
